Financhill

Annual Reports

Per Page: 24
Company
Score
Last Price
Annual Revenues
Last Price:
$134.60
Annual Revenues:
$6.5B
Return on Equity:
21.45%
Last Price:
$28.72
Annual Revenues:
$20B
Return on Equity:
11.72%
Last Price:
$7.10
Annual Revenues:
$20B
Return on Equity:
11.72%
Last Price:
$17.25
Annual Revenues:
$52.8B
Return on Equity:
--
Last Price:
$123.21
Annual Revenues:
$1.2B
Return on Equity:
25.53%
Last Price:
$255.27
Annual Revenues:
$391B
Return on Equity:
140.28%
Last Price:
$15.19
Annual Revenues:
$9.3B
Return on Equity:
10.29%
Last Price:
$54.94
Annual Revenues:
$32.2B
Return on Equity:
27.49%
Last Price:
$178.39
Annual Revenues:
$54.3B
Return on Equity:
58.92%
Last Price:
$1.90
Annual Revenues:
$16B
Return on Equity:
15.48%
Last Price:
$134.52
Annual Revenues:
$9.9B
Return on Equity:
22.05%
Last Price:
$114.31
Annual Revenues:
$40.1B
Return on Equity:
14.78%
Last Price:
$22.39
Annual Revenues:
$15.4B
Return on Equity:
5.08%
Last Price:
$9.70
Annual Revenues:
$5.5B
Return on Equity:
12.08%
Last Price:
$13.80
Annual Revenues:
$98.2B
Return on Equity:
9.32%
Last Price:
$92.09
Annual Revenues:
$13.3B
Return on Equity:
29.78%
Last Price:
$19.63
Annual Revenues:
$79.2B
Return on Equity:
45.13%
Last Price:
$107.92
Annual Revenues:
$16.1B
Return on Equity:
16.66%
Last Price:
$358.77
Annual Revenues:
$64.9B
Return on Equity:
26.41%
Last Price:
$446.74
Annual Revenues:
$21.5B
Return on Equity:
36.84%
Last Price:
$122.43
Annual Revenues:
$23.2B
Return on Equity:
8.09%
Last Price:
$214.89
Annual Revenues:
$9.4B
Return on Equity:
4.63%
Last Price:
$50.41
Annual Revenues:
$93.9B
Return on Equity:
7.6%
No results

Investing News

Is Alphabet an Undervalued Growth Stock to Buy?

Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies in history. As the parent company of Google, Alphabet has stood at the top of the search engine market since the early days of the internet. Today, the company has diversified into everything from making smart devices to providing cloud computing services. Surprisingly, though, Alphabet’s […]

Read Article

Is Tesla Going to Buy Uber?

Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large, dramatic moves as it continues to promote both EV and autonomous driving technologies. One possible decision some investors have speculated Tesla might make in the future is that of buying ridesharing giant Uber. Is there a good argument for Tesla to buy Uber, and how […]

Read Article

NVIDIA vs Broadcom Stock: Which Is Best?

NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company, NVIDIA and Broadcom likely stand out as strong options. But what if you could only choose one company? Would you bet your investment dollars on NVIDIA or Broadcom? It’s no big surprise that the answer depends on what you expect to get in return for […]

Read Article

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and history of Caesars Entertainment goes relatively unnoticed by Wall Street while quietly incubating a high-growth opportunity. The gambling and hospitality giant, which got its start in Reno back in 1937, is better known for iconic casinos and resorts than digital gaming platforms. Yet beneath the […]

Read Article

Will Tyson Foods Stock Bounce Back?

Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food companies in the world. It is a recognized leader in protein and operates through four segments: Beef, Pork, Chicken, and Prepared Foods. The company has many well-known brands, such as Tyson®, Jimmy Dean®, and Hillshire Farm®. These brands help the company be a market leader […]

Read Article

Will Iovance Biotherapeutics Stock Bounce Back?

Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors. There was lots of hype about this next-generation cancer treatment comp

Read Article

More Investing News

The #1 Stock Analysis Tool to Make Smarter Buy and Sell Decisions

Get started at Financhill, the #1 investment research platform that is your one-stop shop for finding the best trade ideas today.

  • Top Rated Stock Ideas
    Financhill Stock Score is a proprietary stock rating engine that independently evaluates every company based on fundamental, technical, and sentiment criteria so you can find the highest rated stocks in the S&P 500, NASDAQ and NYSE.
  • Best Stock Tools Platform
    Whether you are looking for the best blue chip stocks, top dividend stocks, most shorted stocks, cheapest stocks today, highest dividend stocks or best stocks under $50, Financhill has got you covered and has so much more.
  • Stocks Set To Soar & Crash
    Financhill spots seasonal patterns in thousands of stocks so you can easily screen for the best stocks at this time of year. Want to know what stocks could rise 11% over the next 7 weeks with 91% accuracy based on past history? Our Seasonality Screener will surface the hottest stocks right now.
Learn More

Featured in:

CNBC
The Wall Street Journal
Chicago Tribune
Barrons
MSN
Reuters